Lv1
20 积分 2024-10-22 加入
A perspective on AKT 25-plus years after its discovery
13天前
已完结
The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism
17天前
已完结
Deciphering phosphorylation TACtics: Advances in phosphorylation targeting strategies and bifunctional modalities
17天前
已完结
Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer
1个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
1个月前
已完结
AKT as a Therapeutic Target in Cancer
2个月前
已完结
FDA approves 100th small-molecule kinase inhibitor
2个月前
已关闭
Branching beyond bifunctional linkers: synthesis of macrocyclic and trivalent PROTACs
2个月前
已完结
Induced proximity-based therapeutic modalities
3个月前
已完结
A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present)
3个月前
已完结
皖公网安备34019202002308
